Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Boston Scientific and CryoCor collaborate in atrial fibrillation

Boston Scientific and CryoCor collaborate in atrial fibrillation

Novel preclinical gene therapy approach for treating Niemann-Pick disease

Novel preclinical gene therapy approach for treating Niemann-Pick disease

Drug brand name can influence treatment decisions by patients

Drug brand name can influence treatment decisions by patients

Stroke prevalence varies across U.S.

Stroke prevalence varies across U.S.

Ottawa Aggressive Protocol for acute atrial fibrillation is successful

Ottawa Aggressive Protocol for acute atrial fibrillation is successful

Online heart disease education program helps patients

Online heart disease education program helps patients

Cardiotrophin 1 molecule shows potential for diagnosing hypertensive cardiopathy

Cardiotrophin 1 molecule shows potential for diagnosing hypertensive cardiopathy

Treatment with zoledronic acid effective in reducing fractures in women with postmenopausal osteoporosis

Treatment with zoledronic acid effective in reducing fractures in women with postmenopausal osteoporosis

Reclast found to cause abnormal heart rhythms

Reclast found to cause abnormal heart rhythms

Levosimendan compared to dobutamine for decompensated heart failure

Levosimendan compared to dobutamine for decompensated heart failure

Corticosteroids after cardiac surgery lower risk of atrial fibrillation

Corticosteroids after cardiac surgery lower risk of atrial fibrillation

Plavix appears to be safe during and after heart bypass

Plavix appears to be safe during and after heart bypass

Irregular heartbeat linked to genetic mutation

Irregular heartbeat linked to genetic mutation

Elderly atrial fibrillation patients lack adequate application of current management guidelines

Elderly atrial fibrillation patients lack adequate application of current management guidelines

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain

Older patients with atrial fibrillation have higher rates of major hemorrhage in the brain

Guidelines on atrial fibrillation recommend new approach

Guidelines on atrial fibrillation recommend new approach

Likelihood of hemorrhage on warfarin is relatively small

Likelihood of hemorrhage on warfarin is relatively small

Study shows heart drug digitalis safe in patients with diastolic heart failure

Study shows heart drug digitalis safe in patients with diastolic heart failure

Healthy habits and appropriate treatments help prevent stroke

Healthy habits and appropriate treatments help prevent stroke

Corticosteroids may be linked to an increased risk for atrial fibrillation

Corticosteroids may be linked to an increased risk for atrial fibrillation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.